foxo4-dri senolytic peptide animal model 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI improves spermatogenesis in aged
FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect Full article: Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics FOXO4 DRI 10MG Raw Amino Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



